Startups channel feed – Endpoints News

Startups channel feed

Third Rock's Ambys hauls $140M for liver disease, inking Takeda deal ahead of launch

7 years ago

NEA, 5AM back a $50M play to steer gene therapies to the clinic at Akouos — the latest startup in hearing

7 years ago

Stock scandals: Biotech incubator Fortress purchased brokerage firm to tout its own startups — Reuters

7 years ago

Genentech I/O chief Dan Chen heads to an upstart biotech looking to create a landmark advance on antibodies

7 years ago

The Google of CRISPR tech? Tech legends Tim Cook and Jeff Huber back Mammoth Biosciences

7 years ago

Faster, cheaper DNA sequencing gets Omniome $60M led by Chinese investors

7 years ago

Illumina's founding scientist launches software startup to track fast-mutating hospital bugs

7 years ago

Armed with $36M A round, Johns Hopkins spinout Neuraly heads to PhI Parkinson's trial

7 years ago

Boom time: Rubius, Crinetics find big support in upsized IPOs totaling $343M raise

7 years ago

Vivek Ramaswamy strikes again, this time launching a Beijing-based biotech player with a pipeline

7 years ago

The next Nimbus? Head of billion-dollar drug program launches HotSpot with $45M A round

7 years ago

Backers of Tesla and SpaceX fund 29-year-old Alice Zhang's AI-powered neuroscience startup

7 years ago

Thiel-backed Compass adds $49M to A round, bringing total to $132M

8 years ago

Cash-rich Cambridge startup Rubius to build $155M cell therapy manufacturing site in Rhode Island

8 years ago

With tech from Spinraza's maker, French startup Dynacure gets $55M to tackle neuromuscular disease

8 years ago

RIP XTuit: Great brains, hot target and vet CEO Deborah Dunsire in charge couldn’t stop this biotech from going down

8 years ago

CAR macrophage tumor tech created by UPenn star scientists gets $53M

8 years ago

Roivant undergoes major restructuring, cutting and shifting its staff

8 years ago

Food-sourced microbiome drugs get $101M megaround for Flagship's Kaleido

8 years ago

Akero elbows its way into a crowded NASH field, with $65M and a strategy for tackling a blockbuster market

8 years ago

UK startup NodThera banks a $40M round with plans to conquer a closely-studied inflammatory target

8 years ago

J&J opens up a new biotech incubator, polishing the Big Apple's ambitions to create a major hub

8 years ago

With an AstraZeneca cancer drug in one hand, $37M in the other, Shanghai's Alpha Bio zooms into a PhII study

8 years ago

I/O player iTeos lines up a $75M round as it preps for human studies, plans a leap to US hub

8 years ago

First page Previous page 64 65 666768 69 70 Next page Last page